SlideShare una empresa de Scribd logo
1 de 26
MEXICO Medical Device Regulations
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Demographics Estados Unidos Mexicanos  -  United Mexican States   Located in North America between Belize and the US Area: 1,972,550 km 2 Source: CIA - The World Fact book Population: 109,955,400 (7/08 estimate)  31 states + 1 federal district Official language: Spanish  Currency: Peso  [Conversion: 1 US $ = 12.64 pesos]
[object Object],[object Object],[object Object],Life Expectancy
Disease Profile ,[object Object],[object Object],[object Object],[object Object]
Leading Causes of Death Source: World Health Statistics Top ten causes of death, all ages (2002) Causes Deaths % All causes 100 Diabetes mellitus 12 Ischemic heart disease 11 Cerebrovascular disease 6 Perinatal condition 6 Cirrhosis of the liver 5 Chronic obstructive pulmonary disease 4 Lower respiratory infections 3 Congenital anomalies 3 Road traffic accidents 3 Hypertensive heart disease 2
Diabetes Mellitus Source: World Health Statistics
Healthcare Spending ,[object Object],[object Object],[object Object],2004: Popular Insurance (Seguro Popular, SPS) introduced with goal to provide universal health coverage by 2010.  In 2008, the timeline was extended to 2030.
Market ,[object Object],[object Object],[object Object],[object Object],[object Object]
TRADE ,[object Object],[object Object],[object Object],[object Object]
Insulin Infusion Pump ,[object Object],[object Object]
Regulatory Environment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Regulatory Environment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Regulatory Environment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],IMSS
Insulin Infusion Pump ,[object Object],[object Object],[object Object]
Regulatory Requirements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Registration Submission Dossier ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Registration Submission Dossier ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Registration Submission Dossier ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary of Requirements b: plus Salud Approval Certificate Requirement Salud IMSS Certificate to foreign government (CFG) X X b Letter of authorization (for distributor) X List of materials X X List of packaging materials X X Manufacturing flow chart X Labels X Directions for use X X Performance specification X X Finished product drawing X X
Summary of Requirements Requirement Salud IMSS Sterilization parameters (If applicable) X X Sterility test report (If applicable)  X Package integrity tests X Finished product quality control test methods/representative test report X Physical test methods/reports X Stability studies X Clinical publications X Samples X Product brochure X X
Summary of the Process RA representative gets the registration request RA representative Request Legalization Required documents are legalized from the Consulate RA  collates the submission dossier  Local Representative/Distributor submits the dossier to Salud Salud reviews  the dossier Submission Cleared
Advantages ,[object Object],[object Object],[object Object],[object Object],[object Object]
Challenges ,[object Object],[object Object],[object Object],[object Object]
Questions

Más contenido relacionado

La actualidad más candente

ISO 13485.2016 Training (Sample)
ISO 13485.2016 Training (Sample)ISO 13485.2016 Training (Sample)
ISO 13485.2016 Training (Sample)Karen Boyd, ASQ CQA
 
EU Variations-Chandra.pptx
EU Variations-Chandra.pptxEU Variations-Chandra.pptx
EU Variations-Chandra.pptxChandra Mohan
 
An Overview for Software as a Medical Device (SaMD)
An Overview for Software as a Medical Device (SaMD)An Overview for Software as a Medical Device (SaMD)
An Overview for Software as a Medical Device (SaMD)DePuy Synthes
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA sandeep bansal
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in USAnkit Geete
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory pptRohitParkale
 
Medical device clinical evaluation
Medical device clinical evaluationMedical device clinical evaluation
Medical device clinical evaluationMalesh M
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021Annet Visscher
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...DeveshDRA
 
Pharmaceutical Dossier submission
 Pharmaceutical Dossier submission Pharmaceutical Dossier submission
Pharmaceutical Dossier submissionsandeep bansal
 
TrackWise Enterprise Quality Management System
TrackWise Enterprise Quality Management SystemTrackWise Enterprise Quality Management System
TrackWise Enterprise Quality Management SystemJakub Sládeček
 
Product life cycle management
Product life cycle managementProduct life cycle management
Product life cycle managementVikas Rathee
 
Second Party Audit and External Third Party Audit
Second Party Audit and External Third Party AuditSecond Party Audit and External Third Party Audit
Second Party Audit and External Third Party AuditShantanuThakre3
 
21 CFR Part 58 & Data integrity
21 CFR Part 58 & Data integrity21 CFR Part 58 & Data integrity
21 CFR Part 58 & Data integrityAnand Pandya
 

La actualidad más candente (20)

ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
 
ISO 13485.2016 Training (Sample)
ISO 13485.2016 Training (Sample)ISO 13485.2016 Training (Sample)
ISO 13485.2016 Training (Sample)
 
Regulatory Procedures
Regulatory ProceduresRegulatory Procedures
Regulatory Procedures
 
EU Variations-Chandra.pptx
EU Variations-Chandra.pptxEU Variations-Chandra.pptx
EU Variations-Chandra.pptx
 
An Overview for Software as a Medical Device (SaMD)
An Overview for Software as a Medical Device (SaMD)An Overview for Software as a Medical Device (SaMD)
An Overview for Software as a Medical Device (SaMD)
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory ppt
 
Medical device clinical evaluation
Medical device clinical evaluationMedical device clinical evaluation
Medical device clinical evaluation
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021
 
The essential changes in the new pbrer format
The essential changes in the new pbrer formatThe essential changes in the new pbrer format
The essential changes in the new pbrer format
 
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersHow to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning Letters
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
 
Pharmaceutical Dossier submission
 Pharmaceutical Dossier submission Pharmaceutical Dossier submission
Pharmaceutical Dossier submission
 
TrackWise Enterprise Quality Management System
TrackWise Enterprise Quality Management SystemTrackWise Enterprise Quality Management System
TrackWise Enterprise Quality Management System
 
Product life cycle management
Product life cycle managementProduct life cycle management
Product life cycle management
 
Second Party Audit and External Third Party Audit
Second Party Audit and External Third Party AuditSecond Party Audit and External Third Party Audit
Second Party Audit and External Third Party Audit
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting   professor pirouziFda guidance for pharmaceutical post marketing reporting   professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
21 CFR Part 58 & Data integrity
21 CFR Part 58 & Data integrity21 CFR Part 58 & Data integrity
21 CFR Part 58 & Data integrity
 

Destacado

Playa del carmen riviera maya
Playa del carmen riviera mayaPlaya del carmen riviera maya
Playa del carmen riviera mayaJack Douzen
 
Mexican Drug war
Mexican Drug warMexican Drug war
Mexican Drug warlahiru17
 
Fotos riviera maya
Fotos riviera mayaFotos riviera maya
Fotos riviera mayaJack Douzen
 
Mexican drug war
Mexican drug warMexican drug war
Mexican drug warkayteeb61
 
3-3 History of Mexico
3-3 History of Mexico3-3 History of Mexico
3-3 History of MexicoSandy Anthony
 
Mexican Drug War
Mexican Drug WarMexican Drug War
Mexican Drug WarJon Dav
 
The Mexican Drug War
The Mexican Drug WarThe Mexican Drug War
The Mexican Drug WarMrG
 
Frida Kahlo PowerPoint Assignment
Frida Kahlo PowerPoint AssignmentFrida Kahlo PowerPoint Assignment
Frida Kahlo PowerPoint Assignmentsarahburton
 
Mexican Cuisine
Mexican CuisineMexican Cuisine
Mexican CuisineMaadz
 
Mexican food
Mexican food Mexican food
Mexican food 172394856
 
Frida kahlo Biography by Isabel
Frida kahlo Biography by IsabelFrida kahlo Biography by Isabel
Frida kahlo Biography by Isabelisabeleld
 
Mexican Food
Mexican FoodMexican Food
Mexican FoodKarii Liz
 
Frida Kahlo Project
Frida Kahlo ProjectFrida Kahlo Project
Frida Kahlo Projectguest255cf0
 
Mexico- Brief history and Culture
Mexico- Brief history and CultureMexico- Brief history and Culture
Mexico- Brief history and CultureBianca Jane Maaliw
 

Destacado (20)

Mexico presentation
Mexico presentationMexico presentation
Mexico presentation
 
Playa del carmen riviera maya
Playa del carmen riviera mayaPlaya del carmen riviera maya
Playa del carmen riviera maya
 
Mexican Drug war
Mexican Drug warMexican Drug war
Mexican Drug war
 
Fotos riviera maya
Fotos riviera mayaFotos riviera maya
Fotos riviera maya
 
Mexican drug war
Mexican drug warMexican drug war
Mexican drug war
 
3-3 History of Mexico
3-3 History of Mexico3-3 History of Mexico
3-3 History of Mexico
 
Mexican Drug War
Mexican Drug WarMexican Drug War
Mexican Drug War
 
The Mexican Drug War
The Mexican Drug WarThe Mexican Drug War
The Mexican Drug War
 
Mexican food
Mexican foodMexican food
Mexican food
 
Frida Kahlo PowerPoint Assignment
Frida Kahlo PowerPoint AssignmentFrida Kahlo PowerPoint Assignment
Frida Kahlo PowerPoint Assignment
 
Mexican food
Mexican foodMexican food
Mexican food
 
Mexican Cuisine
Mexican CuisineMexican Cuisine
Mexican Cuisine
 
Mexican food
Mexican food Mexican food
Mexican food
 
Frida kahlo Biography by Isabel
Frida kahlo Biography by IsabelFrida kahlo Biography by Isabel
Frida kahlo Biography by Isabel
 
Mexican Food
Mexican FoodMexican Food
Mexican Food
 
Frida Kahlo Project
Frida Kahlo ProjectFrida Kahlo Project
Frida Kahlo Project
 
mexicos food powerpoint
mexicos food  powerpointmexicos food  powerpoint
mexicos food powerpoint
 
Mexican food
Mexican foodMexican food
Mexican food
 
Frida Kahlo'nun Hayatı
Frida Kahlo'nun HayatıFrida Kahlo'nun Hayatı
Frida Kahlo'nun Hayatı
 
Mexico- Brief history and Culture
Mexico- Brief history and CultureMexico- Brief history and Culture
Mexico- Brief history and Culture
 

Similar a My Presentation on Mexico Medical Device Regulations

Recall of ph product
Recall of ph productRecall of ph product
Recall of ph productAhmed Suhail
 
drug registrastion requirements in china ...sonali mishra
drug registrastion requirements in china  ...sonali mishradrug registrastion requirements in china  ...sonali mishra
drug registrastion requirements in china ...sonali mishraSonaliMishra64
 
Alitair presentation august 7 2017
Alitair  presentation august 7 2017Alitair  presentation august 7 2017
Alitair presentation august 7 2017Sushant Thakur
 
Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.ProfDnyaneshwariJosh
 
54278982 ra6675-generics-act-of-1988
54278982 ra6675-generics-act-of-198854278982 ra6675-generics-act-of-1988
54278982 ra6675-generics-act-of-1988Wingielyn Baldoza
 
Dia feb 2010 final presentation webinar 2 mll
Dia feb 2010 final presentation webinar 2 mllDia feb 2010 final presentation webinar 2 mll
Dia feb 2010 final presentation webinar 2 mllguest90636cb
 
Digital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and TrendsDigital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and TrendsInsights10
 
Medical devices update on the thai fda regulatory process and requirements
Medical devices update on the thai fda regulatory process and requirementsMedical devices update on the thai fda regulatory process and requirements
Medical devices update on the thai fda regulatory process and requirementsAtthachaiHomhuan1
 
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...Ccaps Translation and Localization
 
PTCE
PTCEPTCE
PTCEA Rx
 
Rigel Medical-The-Pulse-Issue-4
Rigel Medical-The-Pulse-Issue-4Rigel Medical-The-Pulse-Issue-4
Rigel Medical-The-Pulse-Issue-4Medical IT
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - IntroductionDr. Jigar Vyas
 

Similar a My Presentation on Mexico Medical Device Regulations (20)

New FDA of the Philippines
New FDA of the PhilippinesNew FDA of the Philippines
New FDA of the Philippines
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
 
drug registrastion requirements in china ...sonali mishra
drug registrastion requirements in china  ...sonali mishradrug registrastion requirements in china  ...sonali mishra
drug registrastion requirements in china ...sonali mishra
 
Alitair presentation august 7 2017
Alitair  presentation august 7 2017Alitair  presentation august 7 2017
Alitair presentation august 7 2017
 
China
ChinaChina
China
 
Clinical Trials In Latin America
Clinical Trials In Latin America Clinical Trials In Latin America
Clinical Trials In Latin America
 
law of uaeon medical products
law of uaeon medical productslaw of uaeon medical products
law of uaeon medical products
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.Clinical research : Drug regulatory affairs and Pharmacovigilance.
Clinical research : Drug regulatory affairs and Pharmacovigilance.
 
54278982 ra6675-generics-act-of-1988
54278982 ra6675-generics-act-of-198854278982 ra6675-generics-act-of-1988
54278982 ra6675-generics-act-of-1988
 
Dia feb 2010 final presentation webinar 2 mll
Dia feb 2010 final presentation webinar 2 mllDia feb 2010 final presentation webinar 2 mll
Dia feb 2010 final presentation webinar 2 mll
 
Digital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and TrendsDigital Therapeutics Regulatory Process, Update and Trends
Digital Therapeutics Regulatory Process, Update and Trends
 
Medical devices update on the thai fda regulatory process and requirements
Medical devices update on the thai fda regulatory process and requirementsMedical devices update on the thai fda regulatory process and requirements
Medical devices update on the thai fda regulatory process and requirements
 
CMS Proposal--Valley of Death
CMS Proposal--Valley of DeathCMS Proposal--Valley of Death
CMS Proposal--Valley of Death
 
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...
Requirements in the Life Sciences Industry: A Different Ball-Game?, by Richar...
 
PTCE
PTCEPTCE
PTCE
 
Rigel Medical-The-Pulse-Issue-4
Rigel Medical-The-Pulse-Issue-4Rigel Medical-The-Pulse-Issue-4
Rigel Medical-The-Pulse-Issue-4
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
 
Restricted list final_2010
Restricted list final_2010Restricted list final_2010
Restricted list final_2010
 

My Presentation on Mexico Medical Device Regulations

  • 1. MEXICO Medical Device Regulations
  • 2.
  • 3. Demographics Estados Unidos Mexicanos - United Mexican States Located in North America between Belize and the US Area: 1,972,550 km 2 Source: CIA - The World Fact book Population: 109,955,400 (7/08 estimate) 31 states + 1 federal district Official language: Spanish Currency: Peso [Conversion: 1 US $ = 12.64 pesos]
  • 4.
  • 5.
  • 6. Leading Causes of Death Source: World Health Statistics Top ten causes of death, all ages (2002) Causes Deaths % All causes 100 Diabetes mellitus 12 Ischemic heart disease 11 Cerebrovascular disease 6 Perinatal condition 6 Cirrhosis of the liver 5 Chronic obstructive pulmonary disease 4 Lower respiratory infections 3 Congenital anomalies 3 Road traffic accidents 3 Hypertensive heart disease 2
  • 7. Diabetes Mellitus Source: World Health Statistics
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Summary of Requirements b: plus Salud Approval Certificate Requirement Salud IMSS Certificate to foreign government (CFG) X X b Letter of authorization (for distributor) X List of materials X X List of packaging materials X X Manufacturing flow chart X Labels X Directions for use X X Performance specification X X Finished product drawing X X
  • 22. Summary of Requirements Requirement Salud IMSS Sterilization parameters (If applicable) X X Sterility test report (If applicable) X Package integrity tests X Finished product quality control test methods/representative test report X Physical test methods/reports X Stability studies X Clinical publications X Samples X Product brochure X X
  • 23. Summary of the Process RA representative gets the registration request RA representative Request Legalization Required documents are legalized from the Consulate RA collates the submission dossier Local Representative/Distributor submits the dossier to Salud Salud reviews the dossier Submission Cleared
  • 24.
  • 25.